Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
出版年份 2016 全文链接
标题
Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-11-07
DOI
10.1038/srep36518
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Driver and Passenger Mutations in Cancer
- (2015) Julia R. Pon et al. Annual Review of Pathology-Mechanisms of Disease
- Comprehensive prediction of drug-protein interactions and side effects for the human proteome
- (2015) Hongyi Zhou et al. Scientific Reports
- Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
- (2015) Michaela L. Granados et al. PLoS One
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin
- (2014) Yin-dong Song et al. TUMOR BIOLOGY
- Targeting EGFR and PI3K pathways in ovarian cancer
- (2013) S Glaysher et al. BRITISH JOURNAL OF CANCER
- Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
- (2013) Chee Khoon Lee et al. JNCI-Journal of the National Cancer Institute
- Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents
- (2012) Gang Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: A systematic review
- (2011) Mark Murphy et al. DRUG RESISTANCE UPDATES
- Chemosensitization of cancer cells by siRNA using targeted nanogel delivery
- (2010) Erin B Dickerson et al. BMC CANCER
- Role of Epidermal Growth Factor Receptor Degradation in Cisplatin-Induced Cytotoxicity in Head and Neck Cancer
- (2010) Aarif Ahsan et al. CANCER RESEARCH
- A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)
- (2010) H. Hirte et al. GYNECOLOGIC ONCOLOGY
- Peptide-Functionalized Nanogels for Targeted siRNA Delivery
- (2009) William H. Blackburn et al. BIOCONJUGATE CHEMISTRY
- Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase Activity
- (2008) Zhang Weihua et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started